Upper gastrointestinal stenting during the SARS-CoV-2 outbreak : impact of mitigation measures and risk of contamination for patients and staff
| Autor: | Angels Ginès, Antonio Capogreco, Brigitte Schumacher, Joel Ferreira-Silva, Alessandro Repici, Alessandro Fugazza, Simon Everett, Eduardo Rodrigues-Pinto, David Albers, Guilherme Macedo, Peter D. Siersema |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Original article Medical staff Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Medizin Medicine (miscellaneous) Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] 03 medical and health sciences All institutes and research themes of the Radboud University Medical Center 0302 clinical medicine medicine Upper gastrointestinal Pharmacology (medical) lcsh:RC799-869 Gastrointestinal Stenting business.industry Gastroenterology Outbreak Retrospective cohort study 030220 oncology & carcinogenesis Emergency medicine lcsh:Diseases of the digestive system. Gastroenterology 030211 gastroenterology & hepatology Personal protection equipment business |
| Zdroj: | Endoscopy International Open, 09, E76-E86 Endoscopy International Open Endoscopy International Open, Vol 09, Iss 01, Pp E76-E86 (2021) Endoscopy International Open, 09, 01, pp. E76-E86 |
| ISSN: | 2364-3722 |
| Popis: | Background and study aims The impact of COVID-19 mitigation measures on stent placement procedures has not yet been reported. The aim of this study was to assess the impact of COVID-19 mitigation measures on upper stenting during SARS-CoV-2 outbreak, as well as the use of personal protection equipment (PPE) and risk of contamination for patients and staff. Patients and methods This was a multicenter, retrospective study of consecutive patients who underwent stent placement for upper gastrointestinal obstruction during the second half of SARS-CoV-2 outbreak period in comparison to same period one year before. Results A total of 29 stents were placed for upper gastrointestinal obstruction during the study period, corresponding to an increase of 241 % comparing to the same period in 2019 (n = 12). No significant major differences were found between the two time periods regarding patients’ baseline characteristics, post-stenting management and number of staff involved in stent placement. Fellows’ involvement was significantly lower in 2020 compared to 2019 (21 % vs 67 %; P = 0.01). The majority of procedures were performed using FFP2 /FFP3 mask (76 %), protective eyewear (86 %), two pairs of gloves (65 %), hairnet (76 %) and full disposable gowns (90 %). One patient tested positive for SARS-CoV-2 after the procedure. None of the medical staff involved in stenting procedures developed COVID-19 14 days after procedure. Conclusion Upper gastrointestinal stenting increased during the SARS-CoV-2 outbreak period, which could be related to yearly variation on the number of procedures or reflect a change of oncologic treatment practice during COVID times. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|